There are 209,355 papers on aging in Homo sapiens: 23,041 trials and 129,545 observational studies in people, 5,489 in animals, 4,754 in cells, 36,219 reviews. The newest story, Nov 17, 2026: “RNA delivery restored muscle weight in aged immobilized mice”.
Exercise showed no clear effect on behavioral accuracy in humans (overweight or obesity; food-related Flanker task) (Accuracy p = 0.7978; reaction time p = 0.7221).
“Behavioral accuracy remained high, with no significant overall intervention effect (χ2(2) = 0.452, p = 0.7978).”
Human trialoverweight or obesity; food-related Flanker taskacuten = 17
Exercise is associated with change in metabolic syndrome prevalence in humans (Aggregated sex- and age-group trends among Specific Health Checkup participants) (r = -0.852).
“In males, significant negative correlations were found between changes in MetS prevalence and changes in exercise (r = -0.852) and DPA (r = -0.849).”
HumansAggregated sex- and age-group trends among Specific Health Checkup participants10 years (2014–2023)males
Exercise improves balance function in humans (living in residential care facilities) (MD = 5.56, 95% CrI: 2.68, 8.6 at approximately 900 MET-min/week).
“Overall exercise demonstrated a positive dose–response association with balance improvement, with the greatest benefit observed at approximately 900 MET-min/week”
Reviewliving in residential care facilitiesapproximately 900 MET-min/week
GLP-1 receptor agonists are linked with a higher risk of atopic dermatitis in humans (Genetically proxied exposure in individuals of European ancestry) (OR 1.39, 95% CI 1.26–1.54; p < 0.01).
“Our study suggests that GLP1R agonists may increase the risk of psoriasis and AD.”
HumansGenetically proxied exposure in individuals of European ancestry
GLP-1 receptor agonists are linked with a higher risk of psoriasis in humans (Genetically proxied exposure in individuals of European ancestry) (OR 1.85, 95% CI 1.56–2.20; p < 0.01).
“MR analysis indicated that genetically predicted GLP1R agonist exposure was a risk factor for both psoriasis”
HumansGenetically proxied exposure in individuals of European ancestry
GLP-1 receptor agonists were not clearly linked with cortisol in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users).
“mean cortisol levels were similar between cohorts.”
HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669
GLP-1 receptor agonists are associated with C-reactive protein in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users) (CRP and ESR: both P < 0.001).
“GLP-1RA users also demonstrated significantly lower mean CRP and ESR levels (both P < 0.001)”
HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669
GLP-1 receptor agonists are associated with receipt of major joint injections in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users) (18.93% versus 16.87%; P < 0.001).
“A greater proportion of patients in the GLP-1RA cohort received major joint injections (18.93% vs. 16.87%; P < 0.001)”
HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669
Physical activity is associated with estimated onset of memory decline in humans (Higher physical activity at wave 4 compared with sedentary activity) (2.64 years later).
“Higher physical activity at wave 4, compared with sedentary activity, and social engagement were associated with a later estimated onset of memory decline”
HumansHigher physical activity at wave 4 compared with sedentary activity
Physical activity is associated with mild cognitive impairment in humans (Parkinson's disease) (57.9% lower odds).
“Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”
HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259
Physical activity is associated with diabetes mellitus in humans (Parkinson's disease) (40.6% lower odds).
“Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”
HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259
Physical activity is associated with hypertension in humans (Parkinson's disease) (21.1% lower odds).
“Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”
HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259
Physical activity is associated with metabolic syndrome in humans (Adjusted for potential confounding factors).
“After adjustment for potential confounding factors, the body mass index (BMI), physical activity level, and smoking status were significantly related to the MetS.”
HumansAdjusted for potential confounding factorsn = 14,906
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·
Smoking is associated with senescence-associated gene expression in humans (smokers).
“Spatial transcriptomic analysis of smoker lungs demonstrates parallel alterations marked by increased expression of senescence-associated genes”
Smoking is associated with white matter hyperintensity volume in humans (relapsing compared with non-smoking) (+0.15 standard deviations; 95% CI 0.00–0.30; p=.045).
“Relapsing was associated with 0.15 standard deviations more white matter hyperintensity volume (95%CI[0.00,0.30],p=.045)”
Smoking is associated with KCO in humans (Healthy current smokers compared with never and former smokers) (Median 94% versus 106% in never smokers (p = 0.0003) and 102% in former smokers (p = 0.02)).
“DLCO% and KCO% were lower in current versus never smokers.”
HumansHealthy current smokers compared with never and former smokerslungn = 170
Smoking is associated with within-breath expiratory–inspiratory resistance difference at 5 Hz in humans (Healthy current smokers compared with never and former smokers) (Median 0.57 versus 0.23 in never smokers (p = 0.002) and 0.33 in former smokers (p = 0.006)).
“within-breath expiratory–inspiratory resistance differences were greater in current smokers”
HumansHealthy current smokers compared with never and former smokerslungn = 170
Smoking is associated with proximal serrated lesions in humans (OR 1.4, 95% CI 1.13–1.61).
“Smoking history (odds ratio (OR) 1.4, 95% confidence interval (CI): 1.13–1.61) and daily aspirin use (OR 0.5, 95% CI: 0.33–0.68) were also associated with the risk of proximal SLs.”
SGLT2 inhibitors are associated with maximum anion gap in humans (emergency cardiac surgery with cardiopulmonary bypass) (8.05 ± 2.65 versus 6.08 ± 2.45 mmol/L; p = 0.002).
“The SGLT2i-group exhibited a higher maximum anion gap compared with the non-SGLT2i-group, although values remained within the normal range”
Humansemergency cardiac surgery with cardiopulmonary bypasspostoperativen = 81
SGLT2 inhibitors are associated with Fibrosis-4 Index in humans (type 2 diabetes; adjusted comparison with other therapies) (Adjusted difference -0.13 (95% CI -0.19 to -0.08)).
“The fibrosis-4 index was slightly lower in the inhibitor group”
Humanstype 2 diabetes; adjusted comparison with other therapiesliver6 monthsn = 493
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·
SGLT2 inhibitors were not clearly linked with hepatic steatosis index in humans (type 2 diabetes; additional adjustment for change in body weight) (Adjusted difference 0.12 (95% CI -0.35 to 0.58)).
“After adding the change in body weight to the model, the difference in the hepatic steatosis index disappeared”
Humanstype 2 diabetes; additional adjustment for change in body weightliver6 monthsn = 493
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·
SGLT2 inhibitors are associated with body weight in humans (type 2 diabetes of at least 5 years’ duration; comparison with other therapies) (2.26 kg greater decrease (95% CI −2.70 to −1.83 kg)).
“The body weight fell by 2.26 kg more (95% confidence interval: −2.70 to −1.83).”
Humanstype 2 diabetes of at least 5 years’ duration; comparison with other therapies6 monthsn = 493
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·
SGLT2 inhibitors are associated with hepatic steatosis index in humans (type 2 diabetes of at least 5 years’ duration; adjusted comparison with other therapies) (Adjusted difference −0.69 (95% CI −1.13 to −0.25)).
“The hepatic steatosis index fell more in the inhibitor group”
Humanstype 2 diabetes of at least 5 years’ duration; adjusted comparison with other therapiesliver6 monthsn = 493
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·
SGLT2 inhibitors are associated with atrial fibrillation remission in humans (Patients with type 2 diabetes mellitus after radiofrequency catheter ablation) (67% vs 23% remission; p=0.005).
“The use of sodium-glucose cotransporter-2 inhibitors was associated with a higher remission rate (67% vs 23%; p=0.005).”
HumansPatients with type 2 diabetes mellitus after radiofrequency catheter ablation
SGLT2 inhibitors are associated with diabetic ketoacidosis in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (0.25% vs 0.46%; RR 0.53, 95% CI 0.29–0.98).
“Diabetic ketoacidosis (DKA) events were rare in both groups (0.25% vs 0.46%) but occurred less frequently among SGLT2 inhibitor users”
Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505
SGLT2 inhibitors are associated with acute kidney injury in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (RR 0.89, 95% CI 0.84–0.94).
“AKI (RR: 0.89, 95% CI: 0.84-0.94, p < 0.0001)”
Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505
SGLT2 inhibitors are associated with major adverse respiratory events in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (RR 0.87, 95% CI 0.84–0.91).
“MAREs (RR: 0.87, 95% CI: 0.84-0.91, p < 0.0001)”
Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505
SGLT2 inhibitors are associated with mortality in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (8.72% vs 12.27%; RR 0.71, 95% CI 0.64–0.79).
“SGLT2 inhibitor users had significantly lower 30-day mortality”
Humanstype 2 diabetes mellitus following hospitalization for pneumonia30 daysn = 6,505
Semaglutide decreases eating disorder psychopathology in humans (Obesity treatment; semaglutide versus placebo, both with lifestyle intervention).
“Semaglutide reduced eating disorder psychopathology and improved body image relative to placebo at 20 to 60 weeks of treatment for obesity management.”
Human trialObesity treatment; semaglutide versus placebo, both with lifestyle intervention2.4 mg20 to 60 weeksn = 120
Semaglutide is associated with major adverse cardiovascular events in humans (obesity; compared with bariatric surgery) (HR 0.73, 95% CI 0.58 to 0.91).
“lower rate of major adverse cardiovascular events in the semaglutide cohort (MACE; death, myocardial infarction or stroke; HR 0.73, 95% CI 0.58 to 0.91)”
Semaglutide is linked with lower relative ECG age in humans (obesity; compared with bariatric surgery) (−1.28 years at 12 months (95% CI −2.48 to −0.09); −1.86 years at 21 months (95% CI −3.19 to −0.53)).
“semaglutide was superior to bariatric surgery in reducing relative ECG age: a difference of −1.28 years at 12 months”
Humansobesity; compared with bariatric surgery12 months
Semaglutide raises the risk of diabetic retinopathy complications in humans (SUSTAIN‐6; compared with placebo) (3.0% vs. 1.8%; hazard ratio 1.76, 95% confidence interval 1.11–2.78).
“In SUSTAIN‐6, semaglutide increased DR complications compared with placebo (3.0% vs. 1.8%; hazard ratio 1.76, 95% confidence interval 1.11–2.78)”
↑uphypertension2↓downassociation between ASPA methylation and chronological age1↑upcancer incidence1↑updistal radius fracture1+3+8% cancer cases attributable to alcohol consumptionOR 1.98
6 studies
Alcohol is associated with hypertension in humans (Current alcohol consumption; adjusted analysis) (aPR = 1.74; 95% CI: 1.08–2.78).
“current alcohol consumption was associated with a higher prevalence of measured hypertension”
Alcohol is associated with DNA-methylation-predicted age in humans (Extended model incorporating alcohol consumption, retrained on the combined cohort) (B = −6.84).
“retained alcohol consumption as a significant negative predictor of age ( B = −6.84, p < 0.001)”
HumansExtended model incorporating alcohol consumption, retrained on the combined cohortbuccal swabn = 152
Alcohol is associated with DNA methylation age prediction error in humans (Regular alcohol consumers compared with non-drinkers) (MAE 9.9 versus 7.7 years).
“When applied to the alcohol‐consuming cohort, prediction error increased significantly (MAE = 9.9 years; p = 0.046)”
HumansRegular alcohol consumers compared with non-drinkersbuccal swabn = 62
Alcohol is associated with distal radius fracture in humans (Compared with less than weekly alcohol consumption) (OR 1.98, 95% CI 1.04–3.78; p = 0.038).
“moderate alcohol consumption (1–3 times/week) was associated with higher odds of fracture compared with less than weekly consumption”
HumansCompared with less than weekly alcohol consumption1–3 times/week
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Alcohol is associated with cancer incidence in humans (Population-attributable fraction estimates) (8.0% of cancer cases attributable to alcohol consumption).
“Overall, tobacco smoking and alcohol consumption accounted for 26.8% and 8.0% of cancer cases”
Tirzepatide is associated with body weight in humans (Switching from semaglutide to tirzepatide versus continuing semaglutide) (3.0 kg greater weight reduction (95% CI, 1.2–5.0)).
“switching to tirzepatide produced greater weight reduction than continuing semaglutide (difference of 3.0 kg, 95% CI, 1.2–5.0)”
HumansSwitching from semaglutide to tirzepatide versus continuing semaglutide2 years after target trial emulation enrollmentn = 15,154
Tirzepatide showed no clear effect on serious adverse events in humans (Overweight or obesity; versus placebo).
“The risks of developing any serious AEs with the use of tirzepatide, semaglutide, orlistat, and sibutramine were not statistically different from those with placebo.”
Tirzepatide decreases C-reactive protein in humans (29–55% reduction).
“lowers high-sensitivity C-reactive protein (hsCRP) by 29–55% across randomised trials in obesity, heart failure with preserved ejection fraction and obstructive sleep apnoea”
ReviewTrials in obesity, heart failure with preserved ejection fraction, and obstructive sleep apnea
Tirzepatide decreases episodes of worsening heart failure in humans (People with obesity-related heart failure with preserved ejection fraction in SUMMIT).
“The improvement was mainly related to fewer episodes of worsening heart failure rather than fewer cardiovascular deaths.”
ReviewPeople with obesity-related heart failure with preserved ejection fraction in SUMMIT
↑upadherence to protein intake guideline target1↓downgestational diabetes mellitus1↓downIL-61↓downpulse rate1+1OR 0.41
5 studies
Moderate-to-vigorous physical activity is associated with pulse rate in humans (UK university students; multivariable adjustment and false-discovery-rate correction) (β = −0.146; q = 0.447; not significant).
“Higher MVPA showed directionally lower pulse rate (β = −0.146; q = 0.447) and systolic blood pressure (β = −0.118; q = 0.447), without robust evidence of association.”
HumansUK university students; multivariable adjustment and false-discovery-rate correctionn = 111
Moderate-to-vigorous physical activity is associated with adherence to protein intake guideline target in humans (Japanese adults living in Saga Prefecture).
“moderate-to-vigorous PA and vigorous-intensity PA were positively associated with adherence to the PRT target.”
HumansJapanese adults living in Saga Prefecturen = 2,545
Moderate-to-vigorous physical activity is associated with IL-6 in humans (chronic kidney disease; multivariable adjustment) (B = −0.052 per 30 min/day; 95% CI −0.100 to −0.004; approximately 11.3% lower IL-6).
“Higher MVPA was associated with lower serum IL-6 levels”
Moderate-to-vigorous physical activity is associated with gestational diabetes mellitus in humans (Early pregnancy) (Adjusted OR 0.41, 95% CI 0.16–0.93).
“a total of at least 30 min moderate-to-vigorous physical activity during the previous 7 days (adjusted OR = 0.41, 95% CI: 0.16–0.93)”
HumansEarly pregnancyAt least 30 min during the previous 7 daysfemales
Combined aerobic and resistance training decreases depressive symptoms in humans (treatment-resistant depression; concurrent clomipramine, lamotrigine, and bromazepam) (57% decrease; MADRS 28 to 12).
“Following the intervention, depressive symptoms decreased by 57% (MADRS = 12)”
Human trialtreatment-resistant depression; concurrent clomipramine, lamotrigine, and bromazepamsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1
Combined aerobic and resistance training improves balance function in humans (living in residential care facilities) (MD = 4.72, 95% CrI: 3.23, 6.2 at approximately 710 MET-min/week).
“combined exercise training at approximately 710 MET-min/week (MD = 4.72, 95% CrI: 3.23, 6.2) was the most favorable intervention for improving balance function.”
Reviewliving in residential care facilitiesapproximately 710 MET-min/week
Combined aerobic and resistance training increases maximal oxygen consumption in humans (People living with HIV) (+3.93 mL·kg−1·min−1 (95% CI 3.19 to 4.68)).
“Concurrent training improved VO2max by +3.93 mL·kg−1·min−1 (95% CI 3.19 to 4.68; I2 = 0%)”
Aerobic exercise showed no clear effect on magnitude of the acute exercise response in humans (colorectal cancer survivors; compared with a stretching control program).
“Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes, mitochondrial bioenergetics, or the magnitude of the acute response”
Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20
Aerobic exercise showed no clear effect on T-cell mitochondrial bioenergetics in humans (colorectal cancer survivors; compared with a stretching control program) (Largest between-group difference in tissue-level oxidative phosphorylation capacity: −1.76 pmol·s−1·mL blood−1 (95% CI −3.62 to 0.11); p = 0.065).
“Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes, mitochondrial bioenergetics, or the magnitude of the acute response”
Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20
Aerobic exercise showed no clear effect on resting T-cell phenotypes in humans (colorectal cancer survivors; compared with a stretching control program).
“Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes”
Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20
Aerobic exercise showed no clear effect on cellular-level T-cell mitochondrial oxygen flow in humans (colorectal cancer survivors; baseline assessment).
“without change at the cellular level (all p ≥ 0.74)”
Human trialcolorectal cancer survivors; baseline assessmentmoderate-vigorous intensityT-cellsingle boutn = 20
Resistance training decreases depressive symptoms in humans (Individuals with overweight or obesity; versus control) (SMD −1.456, 95% CrI −2.187 to −0.725).
“resistance training (RT; SMD = −1.456, 95% CrI: −2.187 to −0.725), multicomponent exercise (ME; SMD = −0.942, 95% CrI: −1.644 to −0.240), and aerobic exercise”
ReviewIndividuals with overweight or obesity; versus control
Resistance training increases muscle mass in humans (sarcopenia).
“resistance exercise was the exercise modality with the most consistent evidence for improvements in muscle strength, muscle mass, and physical function”
Resistance training improves muscle strength in humans (sarcopenia).
“resistance exercise was the exercise modality with the most consistent evidence for improvements in muscle strength, muscle mass, and physical function”
Caloric restriction is associated with fasting-associated ketosis with high-anion-gap metabolic acidosis in humans.
“The patient was considered to have fasting-associated ketosis with high-anion-gap metabolic acidosis, compatible with probable starvation ketoacidosis, in the setting of aggressive caloric restriction”
HumansDuring phentermine-assisted weight loss; probable starvation ketoacidosis was not confirmedmales
↔no changebreast cancer risk1↔no changecoronary risk1↓downmenopause Rating Scale total score1
3 studies
Hormone replacement therapy decreases menopause Rating Scale total score in humans (Moderate-to-severe menopausal syndrome; compared with integrative care) (Adjusted mean difference −6.4; 95% CI −7.8 to −5.0).
“HRT produced more rapid symptomatic improvement at 6 months (adjusted mean difference −6.4; 95% confidence interval −7.8 to −5.0; p < 0.001).”
Human trialModerate-to-severe menopausal syndrome; compared with integrative care6 monthsfemalesn = 500
Hormone replacement therapy showed no clear effect on breast cancer risk in humans after risk-reducing salpingo-oophorectomy in women without breast cancer.
“HRT after premenopausal risk‐reducing salpingo‐oophorectomy was not associated with increased breast cancer risk in women without breast cancer”
Reviewafter risk-reducing salpingo-oophorectomy in women without breast cancerfemales
An experiment in aged, immobilized mice used fat-based particles carrying circular RNA for the exercise-induced protein irisin and restored muscle fiber size.An experiment in aged, immobilized mice used fat-based particles carrying circular RNA for the exercise-induced protein irisin and restored muscle fiber size.